A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...

Dr. Aseem Malhotra, a cardiologist and public health campaigner based in London, says Americans' foods are fueling chronic ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

chronic obstructive pulmonary disease (COPD), and ... How a New Gut Microbe Drives the Gut-Lung Axis Dec. 19, 2024 — A team has discovered a new communication pathway between the gut and lung.

In COPD, muscular atrophy is a significant risk factor for death and may prolong patients’ hospital length of stay.

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

A new laser-based device can scan almost any sample of gas and detect its molecular ingredients down to concentrations in the ...

Over half of ICSs do not have enough spirometry testing capacity to meet demand, according to new research by a lung health ...

Patients with chronic obstructive pulmonary disease, interstitial lung disease and pulmonary hypertension experience improved ...

The rising demand for microtomes is largely driven by the growing prevalence of chronic conditions like cancer, cardiovascular diseases such as atherosclerosis, myocardial infarction, and ...

Image credit: Visual Vic/Getty Images. Researchers estimate the number of people globally living with chronic obstructive pulmonary disease (COPD) will hit 600 million by 2050. There are certain ...